Photo of Vijayshree Yadav, M.D.

Vijayshree Yadav M.D.

Dr. Yadav is a board certified neurologist who received her medical degree in 1995 from SN Medical College in Agra, India. She completed  her fellowship in neuroimmunology and multiple sclerosis at Oregon Health & Science University and Portland VA Medical Center in 2004. In 2004, she joined the OHSU MS Center and is an assistant professor in the Department of Neurology. She received her masters in clinical research in 2008 and in 2010 was appointed clinical medical director of the OHSU MS Center.

Dr. Yadav's research interests include complementary and alternative treatment options for multiple sclerosis including dietary and  life style changes as well as supplements such as lipoic acid. She has published several peer reviewed journal articles and presented her research at national and international meetings.

Education

  • M.D., SN Medical College, Agra India 1995
  • Residency:

    • Intern in internal medicine, Westlake Community Hospital, Melrose Park, IL, 1997
  • Fellowship:

    • Neuroimmunology and multiple sclerosis, Oregon Health & Science University and Portland VA Medical Center, 2004
  • Certifications:

    • American Board of Psychiatry and Neurology

Publications

  • "MIF and D-DT are potential disease severity modifiers in male MS subjects." Proceedings of the National Academy of Sciences of the United States of America In: , Vol. 114, No. 40, 03.10.2017, p. E8421-E8429.
  • "Dietary Interventions and Multiple Sclerosis." Current Neurology and Neuroscience Reports  In: , Vol. 17, No. 3, 28, 01.03.2017.
  • "A review of vascular disease risk factors and multiple sclerosis." European Neurological Review  In: , Vol. 13, No. 2, 2017, p. 90-93.
  • "Hypothalamic Dysfunction and Multiple Sclerosis : Implications for Fatigue and Weight Dysregulation." Current Neurology and Neuroscience Reports In: , Vol. 16, No. 11, 98, 01.11.2016.
  • "The contemporary spectrum of multiple sclerosis misdiagnosis." Neurology In: , Vol. 87, No. 13, 27.09.2016, p. 1393-1399.
  • "Low-fat, plant-based diet in multiple sclerosis : A randomized controlled trial." Multiple Sclerosis and Related Disorders  In: , Vol. 9, 01.09.2016, p. 80-90.
  • "Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis." Contemporary Clinical Trials  In: , Vol. 50, 01.09.2016, p. 166-177.
  • "Use of Cannabinoids for Spasticity and Pain Management in MS." Current Treatment Options in Neurology  In: , Vol. 18, No. 1, 1, 01.01.2016, p. 1-14.
  • "Complementary and alternative medical therapies in multiple sclerosis - The American Academy of Neurology Guidelines : A commentary." Clinical Therapeutics  In: , Vol. 36, No. 12, 01.12.2014, p. 1972-1978.
  • "Author response." Neurology  In: , Vol. 83, No. 16, 01.10.2014, p. 1485-1486.
  • "Summary of evidence-based guideline : Complementary and alternative medicine in multiple sclerosis: Report of the Guideline Development Subcommittee of the American Academy of Neurology." Neurology  In: , Vol. 82, No. 12, 25.03.2014, p. 1083-1092.
  • "Perceived Stress in Multiple Sclerosis : The Potential Role of Mindfulness in Health and Well-Being." Journal of Evidence-Based Complementary and Alternative Medicine  In: , Vol. 19, No. 2, 2014, p. 104-111.
  • "New disease-modifying therapies and new challenges for MS." Current Neurology and Neuroscience Reports  In: , Vol. 12, No. 5, 10.2012, p. 489-491.
  • "Recombinant T-cell receptor ligand (RTL) for treatment of multiple sclerosis : A double-blind, placebo-controlled, phase 1, dose-escalation study." Autoimmune Diseases In: , Vol. 1, No. 1, 954739, 2012.
  • "Treat patients with radiologically isolated syndrome when the MRI brain scan shows dissemination in time : No." Multiple Sclerosis  In: , Vol. 18, No. 11, 2012, p. 1529-1530.
  • "Complementary and alternative treatments in multiple sclerosis."  Multiple Sclerosis Therapeutics, Fourth Edition. Cambridge University Press, 2011. p. 562-573.
  • "Cognitive impairment and MS : Searching for effective therapies." Current Neurology and Neuroscience Reports In: , Vol. 11, No. 5, 10.2011, p. 451-454.
  • "The radiologically isolated syndrome revisited : When is it presymptomatic multiple sclerosis?" Neurology  In: , Vol. 76, No. 8, 22.02.2011, p. 680-681.
  • "The effects of omega-3 fatty acids on matrix metalloproteinase-9 production and cell migration in human immune cells : Implications for multiple sclerosis." Autoimmune Diseases  In: , Vol. 1, No. 1, 134592, 2011.
  • "Lipoic acid attenuates inflammation via cAMP and protein kinase A signaling." PLoS One In: , Vol. 5, No. 9, e13058, 28.09.2010.
  • "Oral disease-modifying therapies for multiple sclerosis : Are we there yet?" Current Neurology and Neuroscience Reports  In: , Vol. 10, No. 5, 09.2010, p. 333-335.
  • "Complementary and alternative medicine for the treatment of multiple sclerosis." Expert Review of Clinical Immunology  In: , Vol. 6, No. 3, 05.2010, p. 381-395.
  • "Pharmacokinetic study of acid in multiple sclerosis : Comparing mice and human pharmacokinetic parameters." Multiple Sclerosis In: , Vol. 16, No. 4, 04.2010, p. 387-397.
  • "Memantine for cognitive impairment in multiple sclerosis : A randomized placebo-controlled trial." Multiple Sclerosis In: , Vol. 16, No. 6, 2010, p. 715-723.
  • "Clinical trial of a formal group fatigue program in multiple sclerosis." Multiple Sclerosis In: , Vol. 16, No. 6, 2010, p. 724-732.
  • "Apical Ballooning Resulting from Limbic Encephalitis." American Journal of Medicine  In: , Vol. 122, No. 6, 06.2009, p. 583-586.
  • "Omega-3 fatty acid supplementation decreases matrix metalloproteinase-9 production in relapsing-remitting multiple sclerosis," Prostaglandins Leukotrienes and Essential Fatty Acids In: , Vol. 80, No. 2-3, 02.2009, p. 131-136.
  • "Alemtuzumab versus interferon beta-1a in early multiple sclerosis." Current Neurology and Neuroscience Reports  In: , Vol. 9, No. 5, 2009, p. 341-342.
  • "A randomized pilot study of naturopathic medicine in multiple sclerosis." Journal of Alternative and Complementary Medicine  In: , Vol. 14, No. 5, 01.06.2008, p. 489-496.
  • "Lipoic acid : A novel therapeutic approach for multiple sclerosis and other chronic inflammatory diseases of the CNS." Endocrine, Metabolic and Immune Disorders - Drug Targets In: , Vol. 8, No. 2, 06.2008, p. 132-142.

Additional information

Edit profile